Rein Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Kapnick Scott | — | Purchase | 66,666 | $15.00 | $999,990 | 66,666 | Jul 5, 2017 |
| Apple Tree Partners II - Annex, L.P. | — | C | 655,797 | — | — | 655,797 | Jul 5, 2017 |
| APPLE TREE PARTNERS II LP | — | C | 1,780,564 | — | — | 1,799,586 | Jul 5, 2017 |
| Shanafelt Armen | — | Purchase | 250,000 | $15.00 | $3,750,000 | 1,094,987 | Jul 5, 2017 |
| Lilly Ventures Fund I LLC | — | Purchase | 250,000 | $15.00 | $3,750,000 | 1,094,987 | Jul 5, 2017 |
| AJU IB Investment Co., Ltd. | — | C | 48,656 | — | — | 492,629 | Jul 5, 2017 |
| Gallagher Brian M. Jr. | — | C | 1,158,186 | — | — | 1,158,186 | Jul 5, 2017 |
| Sigma Emerging Markets Ltd. | — | Purchase | 190,000 | $15.00 | $2,850,000 | 423,086 | Jul 5, 2017 |
| Gullans Steven R. Ph.D. | — | Purchase | 60,000 | $15.00 | $900,000 | 1,016,100 | Jul 5, 2017 |
| Satter Muneer A | — | C | 144,773 | — | — | 144,773 | Jul 5, 2017 |
| KCK LTD. | — | C | 446,817 | — | — | 446,817 | Jul 5, 2017 |
| Platt Jon B. | — | C | 90,218 | — | — | 90,318 | Jul 5, 2017 |
| ROCHE HOLDING LTD | — | C | 579,093 | — | — | 582,963 | Jul 5, 2017 |
| CVF, LLC | — | Purchase | 180,000 | $15.00 | $2,700,000 | 716,180 | Jul 5, 2017 |
| Kapnick Scott | — | Purchase | 66,666 | $15.00 | $999,990 | 521,049 | Jul 5, 2017 |
| Ambros Reinhard J. | — | Purchase | 266,667 | $15.00 | $4,000,005 | 2,544,182 | Jul 5, 2017 |
| NOVARTIS AG | — | Purchase | 266,667 | $15.00 | $4,000,005 | 2,544,182 | Jul 5, 2017 |